SILDENAFIL

SILDENAFIL was reported 127803 times

These side effects are most commonly reported by patients taking SILDENAFIL:

# Side effect Count
0 DYSPNOEA 8090
1 HEADACHE 6073
2 DIARRHOEA 4714
3 NAUSEA 4199
4 FATIGUE 4055
5 DEATH 4027
6 DIZZINESS 3520
7 DRUG INEFFECTIVE 3249
8 COUGH 3224
9 PNEUMONIA 2743
10 HYPOTENSION 2493
11 VOMITING 2491
12 OFF LABEL USE 2399
13 MALAISE 2253
14 PAIN 2116
15 PULMONARY ARTERIAL HYPERTENSION 2012
16 CONDITION AGGRAVATED 2003
17 FLUID RETENTION 1992
18 CHEST PAIN 1914
19 PAIN IN EXTREMITY 1875
20 OXYGEN SATURATION DECREASED 1837
21 ASTHENIA 1804
22 PULMONARY HYPERTENSION 1660
23 DYSPNOEA EXERTIONAL 1656
24 WEIGHT DECREASED 1640
25 FALL 1593
26 OEDEMA PERIPHERAL 1533
27 ARTHRALGIA 1523
28 PERIPHERAL SWELLING 1499
29 PAIN IN JAW 1488
30 DECREASED APPETITE 1427
31 PYREXIA 1411
32 FLUSHING 1357
33 SYNCOPE 1353
34 INFUSION SITE PAIN 1226
35 HOSPITALISATION 1203
36 FEELING ABNORMAL 1167
37 NASAL CONGESTION 1128
38 NASOPHARYNGITIS 1124
39 BACK PAIN 1102
40 WEIGHT INCREASED 1100
41 MYALGIA 1097
42 PALPITATIONS 1081
43 CARDIAC FAILURE 1079
44 CHEST DISCOMFORT 1047
45 RIGHT VENTRICULAR FAILURE 1047
46 OEDEMA 1025
47 ANXIETY 1012
48 ABDOMINAL DISCOMFORT 1004
49 INSOMNIA 989
50 ABDOMINAL PAIN UPPER 976
51 RASH 967
52 ANAEMIA 954
53 HYPOXIA 953
54 EPISTAXIS 945
55 RESPIRATORY FAILURE 923
56 THERAPY NON-RESPONDER 876
57 CARDIAC FAILURE CONGESTIVE 834
58 PRODUCT DOSE OMISSION ISSUE 826
59 PULMONARY OEDEMA 818
60 HEART RATE INCREASED 817
61 ABDOMINAL PAIN 816
62 PRURITUS 799
63 ATRIAL FIBRILLATION 776
64 LOSS OF CONSCIOUSNESS 776
65 PRODUCT USE ISSUE 774
66 DISEASE PROGRESSION 767
67 CONSTIPATION 752
68 INFLUENZA 747
69 INFUSION SITE ERYTHEMA 746
70 PRODUCTIVE COUGH 745
71 DEHYDRATION 739
72 ACUTE KIDNEY INJURY 725
73 ABDOMINAL DISTENSION 703
74 FLUID OVERLOAD 671
75 SEPSIS 668
76 URINARY TRACT INFECTION 667
77 COVID-19 662
78 BLOOD PRESSURE DECREASED 659
79 MUSCLE SPASMS 656
80 OROPHARYNGEAL PAIN 643
81 HYPERTENSION 631
82 HAEMOGLOBIN DECREASED 629
83 CARDIAC DISORDER 619
84 SWELLING 611
85 RENAL FAILURE 608
86 SOMNOLENCE 597
87 ERYTHEMA 585
88 DRUG INTERACTION 562
89 CARDIAC ARREST 557
90 GAIT DISTURBANCE 551
91 INFECTION 549
92 DRUG INTOLERANCE 542
93 DYSPEPSIA 541
94 TREMOR 535
95 LUNG DISORDER 532
96 PLEURAL EFFUSION 518
97 THROAT IRRITATION 515
98 UNEVALUABLE EVENT 515
99 TACHYCARDIA 508
100 DEPRESSION 495
101 RHINORRHOEA 495
102 ILLNESS 493
103 CHILLS 492
104 SEASONAL ALLERGY 492
105 MIGRAINE 491
106 GENERAL PHYSICAL HEALTH DETERIORATION 486
107 GASTROINTESTINAL HAEMORRHAGE 481
108 INFUSION SITE SWELLING 469
109 VISION BLURRED 468
110 VISUAL IMPAIRMENT 466
111 HOT FLUSH 449
112 JOINT SWELLING 448
113 ACUTE RESPIRATORY FAILURE 444
114 CONFUSIONAL STATE 441
115 DEVICE DISLOCATION 438
116 DRUG DOSE OMISSION 430
117 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 427
118 HYPERHIDROSIS 425
119 MYOCARDIAL INFARCTION 425
120 GASTROINTESTINAL DISORDER 424
121 ASCITES 418
122 PERICARDIAL EFFUSION 418
123 BLOOD PRESSURE INCREASED 416
124 HAEMOPTYSIS 414
125 DERMATITIS CONTACT 407
126 DEVICE RELATED INFECTION 402
127 HAEMORRHAGE 400
128 PRODUCT USE IN UNAPPROVED INDICATION 396
129 GASTROOESOPHAGEAL REFLUX DISEASE 394
130 SINUSITIS 394
131 PRODUCT DOSE OMISSION 393
132 INCORRECT DOSE ADMINISTERED 392
133 MUSCULAR WEAKNESS 391
134 BRONCHITIS 390
135 CEREBROVASCULAR ACCIDENT 388
136 MEMORY IMPAIRMENT 388
137 DRUG HYPERSENSITIVITY 385
138 TOXICITY TO VARIOUS AGENTS 383
139 TRANSFUSION 381
140 THERAPY INTERRUPTED 376
141 UPPER RESPIRATORY TRACT INFECTION 370
142 PARAESTHESIA 367
143 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 366
144 HYPERSENSITIVITY 363
145 CELLULITIS 361
146 DRUG ABUSE 358
147 PLATELET COUNT DECREASED 357
148 DRY MOUTH 354
149 DEVICE ISSUE 351
150 HYPOAESTHESIA 350
151 WHEEZING 333
152 CATHETER SITE ERYTHEMA 332
153 PREMATURE BABY 324
154 INFUSION SITE HAEMORRHAGE 323
155 SEIZURE 320
156 LUNG TRANSPLANT 318
157 HYPERVOLAEMIA 316
158 OXYGEN CONSUMPTION INCREASED 315
159 PRESYNCOPE 314
160 ALANINE AMINOTRANSFERASE INCREASED 313
161 CHRONIC KIDNEY DISEASE 311
162 TREATMENT NONCOMPLIANCE 311
163 CONTUSION 305
164 BLOOD CREATININE INCREASED 304
165 NECK PAIN 303
166 DEVICE MALFUNCTION 301
167 INJECTION SITE PAIN 299
168 OVERDOSE 298
169 RENAL IMPAIRMENT 296
170 ERECTILE DYSFUNCTION 293
171 ASPARTATE AMINOTRANSFERASE INCREASED 292
172 FOETAL EXPOSURE DURING PREGNANCY 292
173 CATHETERISATION CARDIAC 290
174 FLATULENCE 287
175 THROMBOSIS 287
176 RESPIRATORY DISTRESS 285
177 STRESS 285
178 DEVICE LEAKAGE 281
179 THERAPY CESSATION 281
180 BLOOD POTASSIUM DECREASED 279
181 INFUSION SITE INFECTION 278
182 SWELLING FACE 278
183 INTENTIONAL PRODUCT USE ISSUE 277
184 LETHARGY 276
185 CYANOSIS 273
186 VIRAL INFECTION 270
187 DEVICE OCCLUSION 267
188 THROMBOCYTOPENIA 265
189 BLOOD GLUCOSE INCREASED 259
190 DYSPHONIA 257
191 PULMONARY ARTERIAL PRESSURE INCREASED 257
192 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 256
193 RENAL DISORDER 252
194 BRADYCARDIA 251
195 FEELING HOT 247
196 PULMONARY EMBOLISM 246
197 MATERNAL EXPOSURE DURING PREGNANCY 243
198 CARDIO-RESPIRATORY ARREST 242
199 VASCULAR DEVICE INFECTION 242
200 COMPLICATION ASSOCIATED WITH DEVICE 238
201 CATHETER SITE PAIN 237
202 EXPOSURE DURING PREGNANCY 236
203 INTENTIONAL PRODUCT MISUSE 236
204 ARTHRITIS 234
205 URTICARIA 232
206 DIZZINESS POSTURAL 230
207 INFUSION SITE DISCHARGE 228
208 INTERSTITIAL LUNG DISEASE 226
209 ASTHMA 225
210 PREMATURE DELIVERY 224
211 DRY SKIN 223
212 HEAD INJURY 222
213 NEUROPATHY PERIPHERAL 222
214 ADVERSE EVENT 220
215 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 218
216 RESPIRATORY DISORDER 218
217 TINNITUS 218
218 HYPOKALAEMIA 214
219 SCLERODERMA 213
220 INFLUENZA LIKE ILLNESS 212
221 RECTAL HAEMORRHAGE 212
222 DEVICE INFUSION ISSUE 211
223 DYSPHAGIA 211
224 ARRHYTHMIA 210
225 SINUS DISORDER 209
226 MUSCULOSKELETAL PAIN 208
227 ALOPECIA 205
228 SEPTIC SHOCK 205
229 HAEMATOCHEZIA 204
230 COMA 203
231 BALANCE DISORDER 201
232 LOCALISED INFECTION 201
233 HEART RATE DECREASED 200
234 LIVER DISORDER 200
235 CATHETER SITE PRURITUS 199
236 AGITATION 197
237 DEVICE FAILURE 197
238 RESPIRATORY TRACT CONGESTION 197
239 GOUT 196
240 SLEEP DISORDER 196
241 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 194
242 HERPES ZOSTER 193
243 INFUSION SITE PRURITUS 193
244 LIVER FUNCTION TEST ABNORMAL 192
245 CATHETER SITE HAEMORRHAGE 190
246 BLOOD BILIRUBIN INCREASED 189
247 DEPRESSED MOOD 187
248 BONE PAIN 182
249 POLLAKIURIA 180
250 CATHETER SITE INFECTION 179
251 DIALYSIS 179
252 EXERCISE TOLERANCE DECREASED 178
253 INJECTION SITE ERYTHEMA 178
254 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 178
255 RASH PRURITIC 178
256 DIABETES MELLITUS 177
257 LOWER RESPIRATORY TRACT INFECTION 174
258 PRODUCT SUBSTITUTION ISSUE 174
259 RESPIRATORY TRACT INFECTION 174
260 CATHETER MANAGEMENT 173
261 HYPOACUSIS 173
262 BLINDNESS 171
263 CATHETER SITE DISCHARGE 171
264 THERAPY CHANGE 170
265 HEAD DISCOMFORT 169
266 MENTAL STATUS CHANGES 169
267 MUSCULOSKELETAL STIFFNESS 169
268 AMNESIA 168
269 CARDIOGENIC SHOCK 168
270 HYPERSOMNIA 168
271 BURNING SENSATION 167
272 HEPATIC ENZYME INCREASED 166
273 RETCHING 166
274 STAPHYLOCOCCAL INFECTION 166
275 SKIN ULCER 165
276 EYE PAIN 164
277 VERTIGO 164
278 CONCOMITANT DISEASE AGGRAVATED 163
279 HAEMOGLOBIN INCREASED 162
280 RESPIRATION ABNORMAL 162
281 ADVERSE DRUG REACTION 161
282 PNEUMOTHORAX 161
283 DYSPNOEA AT REST 160
284 HALLUCINATION 158
285 HAEMATOCRIT DECREASED 157
286 NERVOUSNESS 157
287 SINUS CONGESTION 157
288 BLOOD ALKALINE PHOSPHATASE INCREASED 156
289 INTENTIONAL DOSE OMISSION 155
290 SYSTEMIC LUPUS ERYTHEMATOSUS 155
291 CEREBRAL HAEMORRHAGE 154
292 GASTROENTERITIS VIRAL 153
293 HYPOGLYCAEMIA 153
294 EMOTIONAL DISTRESS 152
295 LIMB DISCOMFORT 152
296 TRANSIENT ISCHAEMIC ATTACK 152
297 CARDIAC OPERATION 151
298 CARDIOMEGALY 151
299 PULMONARY CONGESTION 151
300 INFUSION SITE INDURATION 150
301 INTERNATIONAL NORMALISED RATIO INCREASED 150
302 CATARACT 149
303 SURGERY 149
304 OCULAR HYPERAEMIA 148
305 ATRIAL FLUTTER 147
306 SKIN DISCOLOURATION 147
307 CIRCULATORY COLLAPSE 145
308 DISCOMFORT 145
309 HAEMATEMESIS 145
310 INFUSION SITE IRRITATION 145
311 FEELING COLD 144
312 INFUSION SITE REACTION 144
313 BLOOD PRESSURE ABNORMAL 143
314 HIP FRACTURE 143
315 CENTRAL VENOUS CATHETERISATION 142
316 DEVICE USE ERROR 142
317 LIMB INJURY 142
318 INTESTINAL OBSTRUCTION 140
319 HYPONATRAEMIA 139
320 PURULENT DISCHARGE 139
321 CLOSTRIDIUM DIFFICILE INFECTION 138
322 EAR INFECTION 138
323 HEART RATE IRREGULAR 138
324 CARDIAC FAILURE ACUTE 136
325 DISTURBANCE IN ATTENTION 136
326 UNRESPONSIVE TO STIMULI 136
327 INFUSION SITE WARMTH 135
328 SECRETION DISCHARGE 135
329 COMPLETED SUICIDE 134
330 MULTIPLE ORGAN DYSFUNCTION SYNDROME 134
331 PULMONARY FIBROSIS 134
332 WHITE BLOOD CELL COUNT DECREASED 134
333 ANGINA PECTORIS 133
334 MOBILITY DECREASED 133
335 BLISTER 132
336 HEPATIC CIRRHOSIS 132
337 LIP SWELLING 132
338 THERAPY PARTIAL RESPONDER 132
339 BRAIN NATRIURETIC PEPTIDE INCREASED 131
340 DEAFNESS 131
341 WHITE BLOOD CELL COUNT INCREASED 131
342 DEVICE ALARM ISSUE 130
343 INTENTIONAL OVERDOSE 130
344 PALLOR 130
345 PRODUCT ADMINISTRATION INTERRUPTED 130
346 GASTRIC DISORDER 129
347 SUICIDAL IDEATION 129
348 RALES 128
349 GAIT INABILITY 127
350 RESPIRATORY SYNCYTIAL VIRUS INFECTION 127
351 ANGIOEDEMA 126
352 LIVER FUNCTION TEST INCREASED 126
353 ACUTE MYOCARDIAL INFARCTION 125
354 HYPERKALAEMIA 125
355 INTERNAL HAEMORRHAGE 125
356 NEOPLASM MALIGNANT 125
357 DEVICE MAINTENANCE ISSUE 124
358 DYSGEUSIA 124
359 NEPHROLITHIASIS 121
360 NO ADVERSE EVENT 121
361 SUBARACHNOID HAEMORRHAGE 121
362 BLOOD IRON DECREASED 120
363 FAECES DISCOLOURED 120
364 IRRITABILITY 120
365 PANCREATITIS 120
366 SLEEP APNOEA SYNDROME 120
367 VENTRICULAR TACHYCARDIA 120
368 SUBSTANCE USE DISORDER 119
369 EXTRA DOSE ADMINISTERED 118
370 PANIC ATTACK 118
371 DIVERTICULITIS 117
372 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 117
373 OSTEOPOROSIS 117
374 SNEEZING 117
375 BLOOD GLUCOSE DECREASED 116
376 GENERALISED OEDEMA 116
377 PHOTOPHOBIA 116
378 POOR QUALITY SLEEP 116
379 RHABDOMYOLYSIS 116
380 DEVICE BREAKAGE 115
381 DIPLOPIA 115
382 DYSURIA 115
383 RIB FRACTURE 114
384 PULMONARY HAEMORRHAGE 113
385 ROAD TRAFFIC ACCIDENT 113
386 SKIN IRRITATION 113
387 SPUTUM DISCOLOURED 113
388 BLOOD PRESSURE FLUCTUATION 112
389 MELAENA 112
390 SPEECH DISORDER 112
391 PANCYTOPENIA 110
392 COGNITIVE DISORDER 109
393 DECREASED ACTIVITY 108
394 DISORIENTATION 108
395 END STAGE RENAL DISEASE 108
396 LACRIMATION INCREASED 108
397 RESPIRATORY ARREST 108
398 CYSTITIS 107
399 HEPATIC FAILURE 107
400 ILL-DEFINED DISORDER 107
401 ARTHROPATHY 106
402 BLOOD SODIUM DECREASED 106
403 CHOLELITHIASIS 106
404 INJURY 106
405 PULMONARY VENO-OCCLUSIVE DISEASE 106
406 RASH ERYTHEMATOUS 106
407 DEEP VEIN THROMBOSIS 105
408 EYE SWELLING 105
409 MUSCULOSKELETAL CHEST PAIN 105
410 ACCIDENTAL OVERDOSE 104
411 CHOKING SENSATION 104
412 SUDDEN DEATH 104
413 FREQUENT BOWEL MOVEMENTS 103
414 POST PROCEDURAL COMPLICATION 103
415 RHEUMATOID ARTHRITIS 103
416 RHINOVIRUS INFECTION 103
417 BRAIN FOG 102
418 CATHETER SITE SWELLING 102
419 PNEUMONIA ASPIRATION 102
420 RESTLESS LEGS SYNDROME 102
421 RED BLOOD CELL COUNT DECREASED 101
422 TRICUSPID VALVE INCOMPETENCE 101
423 CATHETER PLACEMENT 100
424 MENTAL DISORDER 100
425 LABORATORY TEST ABNORMAL 99
426 RENAL FAILURE ACUTE 99
427 SKIN EXFOLIATION 99
428 INJECTION SITE PRURITUS 97
429 IRON DEFICIENCY ANAEMIA 97
430 OPTIC ISCHAEMIC NEUROPATHY 97
431 PRODUCT QUALITY ISSUE 97
432 RASH MACULAR 97
433 AGEUSIA 96
434 BACTERAEMIA 96
435 FACIAL PAIN 96
436 INFLAMMATION 96
437 JAUNDICE 96
438 PRIAPISM 96
439 NEURALGIA 95
440 RIGHT VENTRICULAR DYSFUNCTION 95
441 THERAPEUTIC RESPONSE UNEXPECTED 94
442 TRANSPLANT EVALUATION 94
443 UPPER GASTROINTESTINAL HAEMORRHAGE 94
444 ANHEDONIA 93
445 BACTERIAL INFECTION 93
446 DEVICE POWER SOURCE ISSUE 93
447 EAR DISCOMFORT 93
448 PSORIASIS 93
449 DYSSTASIA 92
450 HEPATIC FUNCTION ABNORMAL 92
451 MUSCULOSKELETAL DISCOMFORT 92
452 BLOOD POTASSIUM INCREASED 91
453 CHOKING 91
454 PULMONARY HYPERTENSIVE CRISIS 91
455 HAEMATURIA 90
456 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 90
457 FLANK PAIN 89
458 LOCALISED OEDEMA 89
459 PULMONARY THROMBOSIS 89
460 SKIN LACERATION 89
461 TREATMENT FAILURE 89
462 WEIGHT FLUCTUATION 89
463 C-REACTIVE PROTEIN INCREASED 88
464 DRY THROAT 88
465 EAR PAIN 88
466 GASTRITIS 88
467 HOSPICE CARE 88
468 KIDNEY INFECTION 88
469 OSTEOARTHRITIS 88
470 DEVICE CONNECTION ISSUE 87
471 DEVICE WIRELESS COMMUNICATION ISSUE 87
472 EYE PRURITUS 87
473 FEELING JITTERY 87
474 HAEMODYNAMIC INSTABILITY 87
475 BLOOD UREA INCREASED 86
476 HAEMATOMA 86
477 INJECTION SITE SWELLING 86
478 ISCHAEMIC STROKE 86
479 LYMPHADENOPATHY 86
480 NIGHT SWEATS 86
481 OXYGEN SATURATION ABNORMAL 86
482 SUPRAVENTRICULAR TACHYCARDIA 86
483 CARDIAC PACEMAKER INSERTION 85
484 TASTE DISORDER 85
485 UNDERDOSE 85
486 DEVICE DIFFICULT TO USE 84
487 EYE IRRITATION 84
488 DISEASE COMPLICATION 83
489 FEEDING DISORDER 83
490 INJECTION SITE HAEMORRHAGE 83
491 RAYNAUD^S PHENOMENON 83
492 BLOOD PRESSURE SYSTOLIC DECREASED 82
493 NEUTROPHIL COUNT INCREASED 82
494 HAEMORRHOIDS 81
495 INFUSION SITE DISCOMFORT 81
496 INFUSION SITE RASH 81
497 LIVER TRANSPLANT 81
498 PRODUCT DOSE OMISSION IN ERROR 81
499 THROAT TIGHTNESS 81
500 AGGRESSION 80
501 SCIATICA 80
502 SKIN DISORDER 80
503 SKIN INFECTION 80
504 SPINAL FRACTURE 80
505 SUBDURAL HAEMATOMA 80
506 WOUND 80
507 DEVICE PHYSICAL PROPERTY ISSUE 79
508 DYSARTHRIA 79
509 EATING DISORDER 79
510 GAMMA-GLUTAMYLTRANSFERASE INCREASED 79
511 INFUSION SITE NODULE 79
512 THERAPEUTIC RESPONSE DECREASED 79
513 UPPER LIMB FRACTURE 79
514 ACCIDENTAL EXPOSURE TO PRODUCT 78
515 CATHETER SITE IRRITATION 78
516 COLITIS 78
517 CORONARY ARTERY DISEASE 78
518 GALLBLADDER DISORDER 78
519 INFUSION SITE DISCOLOURATION 78
520 LUNG NEOPLASM MALIGNANT 78
521 METABOLIC ACIDOSIS 78
522 ORTHOSTATIC HYPOTENSION 78
523 RESTLESSNESS 78
524 THERAPEUTIC PRODUCT EFFECT DECREASED 78
525 EYE DISORDER 77
526 PROSTATE CANCER 77
527 TOOTHACHE 77
528 ANOSMIA 76
529 ATRIAL TACHYCARDIA 76
530 BODY TEMPERATURE INCREASED 76
531 BRONCHOSPASM 76
532 CATHETER SITE RASH 76
533 DRUG TOLERANCE DECREASED 76
534 HERNIA 76
535 HYPOPHAGIA 76
536 JOINT INJURY 76
537 LUNG INFECTION 76
538 STOMATITIS 76
539 THIRST 76
540 DEVICE RELATED SEPSIS 75
541 DRY EYE 75
542 NASAL DRYNESS 75
543 ORTHOPNOEA 75
544 BLOOD CREATINE PHOSPHOKINASE INCREASED 74
545 DEPRESSED LEVEL OF CONSCIOUSNESS 74
546 ELECTROLYTE IMBALANCE 74
547 PERIPHERAL COLDNESS 74
548 HEART TRANSPLANT 73
549 SUICIDE ATTEMPT 73
550 CHROMATURIA 72
551 FUNGAL INFECTION 72
552 GASTROENTERITIS 72
553 IMPAIRED GASTRIC EMPTYING 72
554 URINARY INCONTINENCE 72
555 BEDRIDDEN 71
556 BLOOD CHOLESTEROL INCREASED 71
557 BLOOD URINE PRESENT 71
558 OROPHARYNGEAL DISCOMFORT 71
559 TACHYPNOEA 71
560 ATELECTASIS 70
561 DRUG DEPENDENCE 70
562 HEPATOMEGALY 70
563 PAIN OF SKIN 70
564 UNINTENTIONAL MEDICAL DEVICE REMOVAL 70
565 CARDIAC FAILURE CHRONIC 69
566 CRYING 69
567 LOW BIRTH WEIGHT BABY 69
568 TENSION HEADACHE 69
569 ACUTE RESPIRATORY DISTRESS SYNDROME 68
570 BLOOD COUNT ABNORMAL 68
571 COLD SWEAT 68
572 CONTRAINDICATED PRODUCT ADMINISTERED 68
573 ENCEPHALOPATHY 68
574 MUSCLE TWITCHING 68
575 SWOLLEN TONGUE 68
576 ANAPHYLACTIC REACTION 67
577 ANKLE FRACTURE 67
578 INJECTION SITE DISCHARGE 67
579 ORAL CANDIDIASIS 67
580 PERICARDITIS 67
581 PRODUCT LEAKAGE 67
582 SMALL INTESTINAL OBSTRUCTION 67
583 URINARY RETENTION 67
584 COAGULOPATHY 66
585 COVID-19 PNEUMONIA 66
586 FOOT FRACTURE 66
587 MUSCLE TIGHTNESS 66
588 POLYURIA 66
589 RESPIRATORY RATE INCREASED 66
590 SHOCK 66
591 DRUG-INDUCED LIVER INJURY 65
592 HYPERGLYCAEMIA 65
593 INFUSION SITE EXTRAVASATION 65
594 ORAL PAIN 65
595 PRODUCT ADMINISTRATION ERROR 65
596 STENT PLACEMENT 65
597 APHASIA 64
598 BLOOD PRESSURE SYSTOLIC INCREASED 64
599 DEMENTIA 64
600 HYPERTHYROIDISM 64
601 LOWER LIMB FRACTURE 64
602 PULMONARY ALVEOLAR HAEMORRHAGE 64
603 INFUSION SITE BRUISING 63
604 INFUSION SITE INFLAMMATION 63
605 LEFT VENTRICULAR FAILURE 63
606 LIGAMENT SPRAIN 63
607 RENAL INJURY 63
608 SLUGGISHNESS 63
609 VASCULITIS 63
610 ABDOMINAL PAIN LOWER 62
611 ANAL INCONTINENCE 62
612 APHONIA 62
613 HEMIPARESIS 62
614 PULMONARY MASS 62
615 PULMONARY PAIN 62
616 CHRONIC RESPIRATORY FAILURE 61
617 DEVICE USE ISSUE 61
618 ERUCTATION 61
619 GENERALISED TONIC-CLONIC SEIZURE 61
620 OXYGEN THERAPY 61
621 PULSELESS ELECTRICAL ACTIVITY 61
622 SUSPECTED COUNTERFEIT PRODUCT 61
623 LIVER INJURY 60
624 MULTIPLE ALLERGIES 60
625 OSTEOMYELITIS 60
626 RIGHT VENTRICULAR DILATATION 60
627 ULCER 60
628 ASPIRATION 59
629 CANDIDA INFECTION 59
630 HEPATIC ENCEPHALOPATHY 59
631 MOOD ALTERED 59
632 PNEUMONITIS 59
633 TYPE 2 DIABETES MELLITUS 59
634 FAECES SOFT 58
635 OCULAR DISCOMFORT 58
636 SARS-COV-2 TEST POSITIVE 58
637 SKIN BURNING SENSATION 58
638 TUBULOINTERSTITIAL NEPHRITIS 58
639 VAGINAL HAEMORRHAGE 58
640 WALKING DISTANCE TEST ABNORMAL 58
641 CARBON DIOXIDE INCREASED 57
642 CARDIAC FLUTTER 57
643 EMPHYSEMA 57
644 EYE HAEMORRHAGE 57
645 GYNAECOMASTIA 57
646 NASAL DISCOMFORT 57
647 SINUS TACHYCARDIA 57
648 TERMINAL STATE 57
649 TRANSAMINASES INCREASED 57
650 UPPER-AIRWAY COUGH SYNDROME 57
651 BLINDNESS UNILATERAL 56
652 DELIRIUM 56
653 HEPATOTOXICITY 56
654 INJECTION SITE BRUISING 56
655 POST PROCEDURAL HAEMORRHAGE 56
656 TOOTH INFECTION 56
657 TROPONIN INCREASED 56
658 URINE OUTPUT DECREASED 56
659 BLOOD MAGNESIUM DECREASED 55
660 CAESAREAN SECTION 55
661 COLITIS ULCERATIVE 55
662 ENDOTRACHEAL INTUBATION 55
663 MULTI-ORGAN FAILURE 55
664 PARACENTESIS 55
665 ABNORMAL BEHAVIOUR 54
666 HEPATIC STEATOSIS 54
667 MUSCLE STRAIN 54
668 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 54
669 DRUG TITRATION ERROR 53
670 FEMUR FRACTURE 53
671 GLAUCOMA 53
672 INFUSION RELATED REACTION 53
673 INJECTION SITE INFECTION 53
674 MECHANICAL VENTILATION 53
675 PARANASAL SINUS DISCOMFORT 53
676 PROCEDURAL PAIN 53
677 TOOTH ABSCESS 53
678 AMMONIA INCREASED 52
679 ECONOMIC PROBLEM 52
680 HEART RATE ABNORMAL 52
681 HIP ARTHROPLASTY 52
682 MALIGNANT MELANOMA 52
683 PARANASAL SINUS HYPERSECRETION 52
684 PETECHIAE 52
685 ASPHYXIA 51
686 BLOOD CULTURE POSITIVE 51
687 CAROTID ARTERY OCCLUSION 51
688 ECZEMA 51
689 FULL BLOOD COUNT DECREASED 51
690 GASTRIC HAEMORRHAGE 51
691 IMPAIRED HEALING 51
692 NIGHTMARE 51
693 PREGNANCY 51
694 THROMBOSIS IN DEVICE 51
695 ABNORMAL LOSS OF WEIGHT 50
696 DYSKINESIA 50
697 IDIOPATHIC PULMONARY FIBROSIS 50
698 INFUSION SITE VESICLES 50
699 MEDICATION ERROR 50
700 MIOSIS 50
701 VISUAL FIELD DEFECT 50
702 BREAST CANCER 49
703 FEBRILE NEUTROPENIA 49
704 INFUSION SITE MASS 49
705 MALNUTRITION 49
706 PACKED RED BLOOD CELL TRANSFUSION 49
707 PANCREATITIS ACUTE 49
708 PNEUMONIA BACTERIAL 49
709 RETINAL VEIN OCCLUSION 49
710 VENTRICULAR FIBRILLATION 49
711 VIRAL UPPER RESPIRATORY TRACT INFECTION 49
712 VISUAL ACUITY REDUCED 49
713 CARDIAC TAMPONADE 48
714 CHOLECYSTECTOMY 48
715 COR PULMONALE 48
716 FACE OEDEMA 48
717 HYPERCAPNIA 48
718 LACTIC ACIDOSIS 48
719 MOOD SWINGS 48
720 MYOPATHY 48
721 NEPHROGENIC ANAEMIA 48
722 OBESITY 48
723 OSTEOPENIA 48
724 CARDIAC ABLATION 47
725 CARDIOMYOPATHY 47
726 CEREBRAL INFARCTION 47
727 CONVULSION 47
728 DISEASE RECURRENCE 47
729 HAEMORRHAGE INTRACRANIAL 47
730 HIGH RISK SEXUAL BEHAVIOUR 47
731 KNEE ARTHROPLASTY 47
732 NEUTROPENIA 47
733 PARANOIA 47
734 PRODUCT PHYSICAL ISSUE 47
735 PRODUCT SUPPLY ISSUE 47
736 SCAR 47
737 SKIN LESION 47
738 TOOTH DISORDER 47
739 TRACHEOSTOMY 47
740 APPETITE DISORDER 46
741 CARDIOPULMONARY FAILURE 46
742 DIABETES MELLITUS INADEQUATE CONTROL 46
743 DRUG WITHDRAWAL SYNDROME 46
744 ERECTION INCREASED 46
745 FEAR 46
746 GINGIVAL BLEEDING 46
747 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 46
748 INJECTION SITE RASH 46
749 MACULOPATHY 46
750 MANIA 46
751 NO THERAPEUTIC RESPONSE 46
752 OBSTRUCTIVE AIRWAYS DISORDER 46
753 SLEEP TERROR 46
754 VASODILATATION 46
755 ALTERED STATE OF CONSCIOUSNESS 45
756 GLYCOSYLATED HAEMOGLOBIN INCREASED 45
757 IMPAIRED QUALITY OF LIFE 45
758 IRRITABLE BOWEL SYNDROME 45
759 MENORRHAGIA 45
760 MOUTH HAEMORRHAGE 45
761 PARKINSON^S DISEASE 45
762 PROCEDURAL COMPLICATION 45
763 PRODUCT USE COMPLAINT 45
764 RETINAL ARTERY OCCLUSION 45
765 VENTILATION PERFUSION MISMATCH 45
766 ABSCESS 44
767 AUTOIMMUNE DISORDER 44
768 BLOOD TEST ABNORMAL 44
769 CATHETER SITE INFLAMMATION 44
770 CHOLECYSTITIS 44
771 DIZZINESS EXERTIONAL 44
772 ELECTROCARDIOGRAM QT PROLONGED 44
773 EXPOSURE VIA SKIN CONTACT 44
774 HAEMODIALYSIS 44
775 INJECTION SITE IRRITATION 44
776 INJECTION SITE REACTION 44
777 MYDRIASIS 44
778 ONYCHOMYCOSIS 44
779 PHARYNGITIS 44
780 PRURITUS GENITAL 44
781 SARCOIDOSIS 44
782 SCRATCH 44
783 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 44
784 BRAIN OEDEMA 43
785 CARDIOSPASM 43
786 CONCOMITANT DISEASE PROGRESSION 43
787 DRUG EFFECT INCOMPLETE 43
788 INFUSION SITE CELLULITIS 43
789 PALMOPLANTAR KERATODERMA 43
790 POISONING 43
791 RIGHT VENTRICULAR HYPERTROPHY 43
792 SENSITIVITY TO WEATHER CHANGE 43
793 SUDDEN CARDIAC DEATH 43
794 SYSTEMIC SCLERODERMA 43
795 ACUTE PULMONARY OEDEMA 42
796 APATHY 42
797 ARTHROPOD BITE 42
798 CARDIAC MURMUR 42
799 CARDIOVERSION 42
800 CLOSTRIDIUM DIFFICILE COLITIS 42
801 COLON CANCER 42
802 DERMATITIS ATOPIC 42
803 EMERGENCY CARE 42
804 EMOTIONAL DISORDER 42
805 FRUSTRATION TOLERANCE DECREASED 42
806 GASTRIC ULCER 42
807 MITRAL VALVE INCOMPETENCE 42
808 NOCTURNAL DYSPNOEA 42
809 PSORIATIC ARTHROPATHY 42
810 QUALITY OF LIFE DECREASED 42
811 SEROTONIN SYNDROME 42
812 SINUS HEADACHE 42
813 STAPHYLOCOCCUS TEST POSITIVE 42
814 THYROID DISORDER 42
815 WRONG DOSE 42
816 ANGER 41
817 APPLICATION SITE ERYTHEMA 41
818 BACK DISORDER 41
819 CHORIORETINOPATHY 41
820 FOETAL GROWTH RESTRICTION 41
821 HIATUS HERNIA 41
822 HYPOAESTHESIA ORAL 41
823 LOCAL SWELLING 41
824 LOWER GASTROINTESTINAL HAEMORRHAGE 41
825 NEPHROPATHY 41
826 PLASMA CELL MYELOMA 41
827 PRODUCT PRESCRIBING ISSUE 41
828 RASH PAPULAR 41
829 ANURIA 40
830 BONE DENSITY DECREASED 40
831 CARDIAC VALVE DISEASE 40
832 FAILURE TO THRIVE 40
833 INTERVERTEBRAL DISC PROTRUSION 40
834 LUNG INFILTRATION 40
835 MYOCARDIAL ISCHAEMIA 40
836 PHARYNGEAL SWELLING 40
837 PRODUCT PRESCRIBING ERROR 40
838 ROTATOR CUFF SYNDROME 40
839 TEMPERATURE INTOLERANCE 40
840 TRANSPLANT 40
841 ACIDOSIS 39
842 ACUTE HEPATIC FAILURE 39
843 APPLICATION SITE PRURITUS 39
844 DRUG LEVEL INCREASED 39
845 DYSCHROMATOPSIA 39
846 EXPIRED PRODUCT ADMINISTERED 39
847 GLOMERULAR FILTRATION RATE DECREASED 39
848 HEPATITIS 39
849 INCORRECT DRUG ADMINISTRATION RATE 39
850 INFUSION SITE ABSCESS 39
851 MOUTH ULCERATION 39
852 PARAESTHESIA ORAL 39
853 RESPIRATORY TRACT INFECTION VIRAL 39
854 SKIN REACTION 39
855 ACNE 38
856 BLOOD PRESSURE DIASTOLIC INCREASED 38
857 BOWEL MOVEMENT IRREGULARITY 38
858 CARPAL TUNNEL SYNDROME 38
859 CATHETER SITE RELATED REACTION 38
860 DERMATITIS ALLERGIC 38
861 DEVICE ADHESION ISSUE 38
862 DEVICE INFORMATION OUTPUT ISSUE 38
863 ECHOCARDIOGRAM ABNORMAL 38
864 EJECTION FRACTION DECREASED 38
865 ELECTROCARDIOGRAM ABNORMAL 38
866 EMBOLISM 38
867 EPILEPSY 38
868 EYE INFECTION 38
869 HYPOTONIA 38
870 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 38
871 INFUSION SITE OEDEMA 38
872 INSURANCE ISSUE 38
873 MENTAL IMPAIRMENT 38
874 PELVIC FRACTURE 38
875 REHABILITATION THERAPY 38
876 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 38
877 SPLENOMEGALY 38
878 STAPHYLOCOCCAL SEPSIS 38
879 BACK INJURY 37
880 BLADDER CANCER 37
881 DEVICE KINK 37
882 EAR CONGESTION 37
883 FOOD POISONING 37
884 HAEMATOLOGICAL INFECTION 37
885 HEPATIC CONGESTION 37
886 HYPERBILIRUBINAEMIA 37
887 HYPOMAGNESAEMIA 37
888 HYSTERECTOMY 37
889 INTERNATIONAL NORMALISED RATIO DECREASED 37
890 JOINT STIFFNESS 37
891 MICTURITION URGENCY 37
892 PHARYNGITIS STREPTOCOCCAL 37
893 TENDERNESS 37
894 TOOTH EXTRACTION 37
895 BRAIN INJURY 36
896 BREATH SOUNDS ABNORMAL 36
897 DEAFNESS UNILATERAL 36
898 DRUG ADMINISTRATION ERROR 36
899 HAEMORRHOIDAL HAEMORRHAGE 36
900 HYPOTHYROIDISM 36
901 LOSS OF LIBIDO 36
902 MUSCLE ATROPHY 36
903 OSTEONECROSIS 36
904 PRESCRIBED OVERDOSE 36
905 PRODUCT AVAILABILITY ISSUE 36
906 PSEUDOMONAS INFECTION 36
907 SKIN HAEMORRHAGE 36
908 TOOTH LOSS 36
909 WOUND INFECTION 36
910 ASPIRATION PLEURAL CAVITY 35
911 BLOOD LOSS ANAEMIA 35
912 CARDIOVASCULAR DISORDER 35
913 CONJUNCTIVITIS 35
914 CROHN^S DISEASE 35
915 DEPRESSIVE SYMPTOM 35
916 DERMATITIS 35
917 DRUG EFFECT LESS THAN EXPECTED 35
918 FULL BLOOD COUNT ABNORMAL 35
919 INTRA-ABDOMINAL FLUID COLLECTION 35
920 IRON DEFICIENCY 35
921 LEUKOCYTOSIS 35
922 MIDDLE INSOMNIA 35
923 SCAB 35
924 SHOCK HAEMORRHAGIC 35
925 STAPHYLOCOCCAL BACTERAEMIA 35
926 SUBSTANCE ABUSE 35
927 TACHYARRHYTHMIA 35
928 VASCULAR DEVICE OCCLUSION 35
929 BONE DISORDER 34
930 CATHETERISATION CARDIAC ABNORMAL 34
931 FIBROMYALGIA 34
932 HEART VALVE INCOMPETENCE 34
933 HERNIA REPAIR 34
934 HYPOVOLAEMIA 34
935 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 34
936 LARGE INTESTINE POLYP 34
937 MACULAR DEGENERATION 34
938 NEEDLE ISSUE 34
939 ORAL DISCOMFORT 34
940 OVARIAN CYST 34
941 PATIENT DISSATISFACTION WITH TREATMENT 34
942 PHOTOSENSITIVITY REACTION 34
943 PLATELET COUNT INCREASED 34
944 PSYCHOTIC DISORDER 34
945 APNOEA 33
946 BLOOD PRESSURE DIASTOLIC ABNORMAL 33
947 BLOOD PRESSURE DIASTOLIC DECREASED 33
948 DIARRHOEA HAEMORRHAGIC 33
949 HALLUCINATION, AUDITORY 33
950 HALLUCINATION, VISUAL 33
951 HEART SOUNDS 33
952 HYPOCALCAEMIA 33
953 HYPOKINESIA 33
954 JOINT DISLOCATION 33
955 LACERATION 33
956 MULTIPLE SCLEROSIS RELAPSE 33
957 PAINFUL RESPIRATION 33
958 POLYCYTHAEMIA 33
959 PROLONGED EXPIRATION 33
960 PULMONARY ARTERIAL PRESSURE ABNORMAL 33
961 SICKLE CELL ANAEMIA WITH CRISIS 33
962 ATRIAL SEPTAL DEFECT 32
963 BASAL CELL CARCINOMA 32
964 DEAFNESS NEUROSENSORY 32
965 DRUG USE DISORDER 32
966 GROIN PAIN 32
967 HYPERPARATHYROIDISM SECONDARY 32
968 MOVEMENT DISORDER 32
969 NOCTURIA 32
970 PRURITUS GENERALISED 32
971 RASH GENERALISED 32
972 RENAL TUBULAR NECROSIS 32
973 SKIN CANCER 32
974 TRISMUS 32
975 ABORTION INDUCED 31
976 CHOLESTASIS 31
977 DIASTOLIC DYSFUNCTION 31
978 DISABILITY 31
979 FACE INJURY 31
980 GASTROINTESTINAL INFECTION 31
981 HEAVY MENSTRUAL BLEEDING 31
982 HYPERLIPIDAEMIA 31
983 HYPERVENTILATION 31
984 INABILITY TO AFFORD MEDICATION 31
985 INCREASED TENDENCY TO BRUISE 31
986 INGUINAL HERNIA 31
987 LYMPHOCYTE COUNT ABNORMAL 31
988 MASS 31
989 MIDDLE EAR EFFUSION 31
990 MULTIPLE SCLEROSIS 31
991 PRODUCT DISPENSING ERROR 31
992 PRODUCT DISTRIBUTION ISSUE 31
993 PRODUCT PREPARATION ERROR 31
994 SKIN FISSURES 31
995 SUTURE RELATED COMPLICATION 31
996 ACCIDENT 30
997 APPENDICITIS 30
998 ATRIAL SEPTAL DEFECT REPAIR 30
999 BLINDNESS TRANSIENT 30